Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Vicor Forecast Q4 Profit At Essentially Breakeven Level - Quick Facts

RELATED NEWS
Trade VICR now with 

Vicor Corp. (VICR: Quote) Monday said it expects fourth-quarter earnings in an essentially break-even level, flat with prior-quarter. Based on existing backlog, the company has forecast a loss for the first quarter of 2013.

The company has been experiencing eight consecutive quarters of declining earnings, largely attributable to weak demands, lower volumes and higher expenses.

"In the fourth quarter of 2012, our bookings activity has slowed; through November 23. This reduction in orders has caused us to reassess our expectations for revenue and earnings for the fourth quarter of 2012 and the first quarter of 2013, " said Patrizio Vinciarelli, Vicor's Chairman of the Board and CEO.

Click here to receive FREE breaking news email alerts for Vicor Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A Thai company has bought iconic U.S. tuna brand Bumble Bee for $1.51 billion dollars. Thai Union Frozen Products Public Company Limited or TUF, the world's largest processor of shelf-stable tuna products snapped up Bumble Bee from private equity firm Lion Capital. Post Synergies, the transaction... Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and... Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.